InterQual Molecular Diagnostics Criteria: Controlling Molecular & Genetic Test Spend
Print page        
share Share this page

November 19, 2009

InterQual Molecular Diagnostics Criteria: Controlling Molecular & Genetic Test Spend 

Thursday, November 19, 2:30-3:00 pm ET


InterQual Molecular Diagnostics Criteria are the only comprehensive, evidence-based criteria focused on the rapidly growing area of molecular and genetic testing for use at the point of care.  Whether to support UM program expansion, or to inform molecular and genetic testing policies, health plans can derive immediate ROI from this new offering. In this session, you will gain an understanding of what areas the criteria cover, how they are organized and the range of options McKesson offers to help your organization get the most from this new criteria set..


You will learn:

  • The InterQual Molecular Diagnostics Criteria offering and current health plan issues it addresses

  • Molecular diagnostic test trends by test type and how the criteria address those by “family”

  • InterQual Molecular Diagnostics Criteria deployment features in Review Manager software and the Clear Coverage automated authorization solution

  • Special programs to help size health plan molecular diagnostics volume and spend

Presenter:  Laura Coughlin, AVP, Clinical Strategy, McKesson Health Solutions 




Dates: November 19, 2009 @2:30pm EST

Audience: Payors, Nurses

Category: Webinars

Business Unit: McKesson Health Solutions

Register: Click Here to Register



© 2010 McKesson Corp.